Gene and protein expressions induced by 17β-estradiol and parathion in cultured breast epithelial cells

Molecular Medicine

Volumn 13, Issue 5-6, 2007, Pages 255-265

  Calaf, Gloria M ^a,b   Roy, Debasish ^c  

^a UNIVERSIDAD DE TARAPACÁ   (Chile)

^b NewYork Presbyterian Hospital   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A1; CYCLIN A2; CYCLIN C; CYCLIN DEPENDENT KINASE; CYCLIN G1; CYCLIN G2; CYCLIN H; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ORGANOPHOSPHATE PESTICIDE; PARATHION; PESTICIDE; RAC PROTEIN; RAC3 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL CULTURE; CELL CYCLE; CELL CYCLE REGULATION; CELL IMMORTALIZATION; CELL STRAIN MCF 10; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MINICHROMOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST; CELLS, CULTURED; EPITHELIAL CELLS; ESTRADIOL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; PARATHION; PROTEINS;

EID: 34547478674     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00087.Calaf     Document Type: Article

References (63)

1. Davis DL, Axelrod D, Bailey L, Gaynor M and Sasco AJ. (1998) Rethinking breast cancer risk and the environment: the case for the precautionary principle. Environ. Health Perspect. 106:523-9.
2. Krieger N (1989) Exposure, susceptibility and breast cancer risk: a hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence. Breast Cancer Res. Treat. 13:205-23.
3. Perera FP (1997) Environment and cancer: who are susceptible? Science. 278:1068-73.
4. Bernstein L, Ross RK. (1993) Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15:48-65.
5. Henderson BE, Ross R, Bernstein L. (1988) Estrogen as a cause of human cancer. The Richard and Hinda Rosenthal Foundations award lecture. Cancer Res. 48:246-53.
6. Kelsey JL, Gammon MD, John EM. (1993) Reproductive factors in breast cancer. Epidemol. Rev.15:36-47.
7. Pike MC, Spicer DV, Dahmoush L, Press MF. (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 15:17-35.
8. Khayat D et al. (1994) Fotemustine in the treatment of brain primary tumors and metastases. Cancer Invest. 12:414-20.
9. Patel SV. (1995) Pharmacotherapy of cognitive impairment in Alzheimer's disease: A review. J. Geriatr. Psychiatry Neurol. 8:81-95.
10. Gunderson CH, Lehmann CR, Sidell FR, Jabbari B. (1992) Nerve agents: a review. Neurology. 42:946-50.
11. Meinking TL et al. (2001) Comparative efficacy of treatments for pediculosis capitis infestations: update 2000. Arch. Dematol. 137:287-92.
12. Klaasen C. (1990) Nonmetallic environmental toxicants: air pollutants, solvents and vapors, and pesticides. In: The Pharmacological Basis of Therapeutics. Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds). New York NY Pergamon Press, Inc., p. 1615-35.
13. Shackney SE, Shankey TV. (1997) Common pattern of genetic evolution in human solid tumors. Cytometry. 29:1-27.
14. Ingvarsson S. (1999) Molecular genetics of breast cancer progression. Semin. Cancer Biol. 9:277-88.
15. Janocko LE et al. (1995) Assessing sequential oncogene amplification in human breast cancer. Cytometry. 21:18-22.
16. Schwab M, Varmus HE, Bishop JM. (1984) Amplification of cellular oncogenes in tumor cells. In: Cancer Cells. Vande Woude GF (ed). Cold Spring Harbor Laboratory, p. 215-20.
17. Knudson AG. (1985) Hereditary cancer, oncogenes and antioncogenes. Cancer Res. 45:1437-43.
18. Bonfil RD et al. (1989) Invasive and metastatic potential of a v-Ha-ras transformed human bronchial epithelial cell line. J. Natl. Cancer Inst. 81:587-94.
19. Calaf G, Hei TK. (2000) Establishment of a radiation-and estrogen-induced breast cancer. Carcinogenesis. 21:769-76.
20. Loeb LA. (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:3075-9.
21. Shen Q, Brown PH. (2003) Novel agents for the prevention of breast cancer: targeting transcription factors and signal transduction pathways. J. Mammary Gland Biol. Neoplasia. 8:45-73.
22. Calaf G, Russo J. (1993) Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis. 14:483-92.
23. Calaf G, Russo J, Alvarado ME. (2000) Morphological phenotypes in neoplastic progression of benz (alpha) pyrene-treated breast epithelial cells. J. Submicrosc. Cytol. Pathol. 32:535-45.
24. Calaf G, Russo J, Tait L, Estrada S, Alvarado ME. (2000) Morphological phenotypes in neoplastic progression of human breast epithelial cells. J. Submiscrosc. Cytol. Pathol. 32:83-96.
25. Calaf G, Hei TK. (2001) Oncoprotein expressions in human breast epithelial cells transformed by high-LET radiation. Int. J. Radiat. Biol. 77:31-40.
26. Zhang P, Calaf G, and Russo J. (1994) Allele loss and point mutation in codon 12 and 61 of the c -Ha-ras oncogene in carcinogen-transformed human breast epithelial cells. Molecular Carcinogenesis.9:46-56.
27. Hei TK, Piao CQ, Willey JC, Thomas S, Hall EJ (1994) Malignant transformation of human bronchial epithelial cells by radon-simulated a particles. Carcinogenesis. 15:431-7.
28. Rhim JS, Dritschilo A. (1993) Neoplastic transformation in human cell systems - An overview. In: Neoplastic Transformation in Human Cell Culture: Mechanisms of Carcinogenesis. Rhim JS, Dritschilo A (eds). Totowa NJ Human Press, p. 11-31.
29. Riches AC, Herceg Z, Bryant PE, Wynford-Thomas D. (1994) Radiation-induced transformation of SV40-immortalized human thyroid epithelial cells by single and fractionated exposure to gamma-irradiation in vitro. Int. J. Radiat. Biol. 66:757-65.
30. Thraves PJ, Salehi Z, Dristchilo A, Rhim JS. (1990) Neoplastic transformation of immortalized human epidermal keratinocytes by ionizing radiation. Proc. Natl. Acad. Sci. USA. 87:1174-7.
31. Soule HD et al. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line. MCF-10F. Cancer Res. 50:6075-86.
32. Calaf G. (2006) Susceptibility of breast epithelial cells in vitro to hormones and drugs. Int. J. Oncol. 28:285-95.
33. Calaf G, Alvarado M, Hei TK. (2005) Beta catenin is associated with breast cancer progression in vitro. Int. J. Oncol. 26:913-21.
34. Calaf G, Alvarado ME, Hei TK. (2005) Oncoprotein expression and morphological phenotypes of human breast epithelial cell transformed by c-Ha-ras oncogene. Oncol. Rep. 14:885-93.
35. Calaf G, Roy D, Hei TK. (2005) Immunochemical analysis of protein in breast epithelial cells transformed by estrogens and high linear energy transfer (LET) radiation. Histochem. Cell Biol. 124:261-74.
36. Sambrook J, Fritsch EF, Maniatis T. (1989) Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2;7.3.
37. Roy D, Calaf G, Hei TK. (2001) Profiling of differentially expressed genes induced by high-LET radiation in breast epithelial cells. Mol. Carcinog. 31:192-203.
38. Lui WM et al. (2002) Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics. 18:1596-99.
39. Dich J, Zahm SH, Hanberg A, Adami HO. (1997) Pesticides and cancer. Cancer Causes Control. 8:420-43.
40. Cabello G et al. (2001) A rat mammary tumor model induced by the organophosphorous pesticides parathion and malathion, possibly through acetylcholinesterase inhibition. Environ. Health Perspect. 109:471-9.
41. Calaf GM, Parra E, Garrido F. (2007) Cell proliferation and tumor formation by eserine an acetylcholinesterase inhibitor in rat mammary gland. Oncol. Rep. 17:25-33.
42. Russo J, Calaf G, Russo IH (1993) A critical approach to the malignant transformation of human breast epithelial cells with chemical carcinogens. Crit. Rev. Oncog. 4:403-17.
43. Russo J et al. (1993) Critical steps in breast carcinogenesis. An. NY Acad. Sci. 698:1-20.
44. Welsh CW. (1982) Hormones and murine mammary tumorigenesis: an historical view. In: Hormonal Regulation of Mammary Tumors. Ed. BS Leung (ed). Montreal, Canada: Eden Press, p. 1-29.
45. Reynolds FH Jr, Todaro GJ, Fryling C, Stephenson JR. (1981) Human transforming growth factors induces tyrosine phosphorylation of EGF receptors. Nature. 292:259-62.
46. Hines SJ, Litz JS, Krystal GW. (1999) Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors. Breast Cancer Res. Treat. 58:1-10.
47. Ko CD et al. (2003) The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium. Clin. Exp. Metastasis. 20:593-7.
48. Hall A. (1990) The cellular functions of small GTP-binding proteins. Science. 249:635-40.
49. Debant A et al. (1996) The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. Proc. Natl. Acad. Sci. USA. 93:5466-71.
50. Elson A, Leder P. (1995) Protein tyrosine phos-phatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-Ras OR neu. J. Biol. Chem. 270:26116-22.
51. Didsbury J, Weber RF, Bokoch GM, Evans T, Snyderman R. (1989) rac, a novel ras-related family of proteins that are botulinum toxin substrates. J. Biol. Chem. 264:16378-82.
52. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B. (2002) Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer. 87:635-44.
53. Kleer CG et al. (2003) Characterization of Rho-C expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol. 160:579-84.
54. Madaule P, Axel R. (1985) A novel ras-related gene family. Cell. 41:31-40.
55. Olofsson B, Chardin P, Touchot N, Zahraoui A, Tavitian A. (1988) Expression of the ras-related ralA, rho 12 and rab genes in adult mouse tissues. Oncogene. 3:231-4.
56. Yeramian P, Chardin P, Madaule P, Tavitian A. (1987) Nucleotide sequence of human Rho cDNA clone 12. Nucleic Acids Res.15:1869.
57. Levine AJ, Momand J, Finlay CA. (1991) The p53 tumour suppressor gene. Nature. 351:453-6.
58. Callahan R. (1992) p53 mutations, another breast cancer prognostic factor. J. Natl. Cancer Inst. 84:826-7.
59. Moll UM, Ostermeyer AG, Ahomadegbe JC, Mathieu MC, Riou G. (1995) p53 mediated tumor cell response to chemotherapeutic DNA damage: a preliminary study in matched pairs of breast cancer biopsies. Hum. Pathol. 26:1293-301.
60. Nigro JM et al. (1989). Mutations in p53 gene occur in diverse human tumour types. Nature. 342:705-8.
61. Roy D, Calaf G, Hei TK. (2001) Frequent allelic imbalance on chromosome 6 and 17 correlation with radiation induced- neoplastic transformation in human breast epithelial cell. Carcinogenesis. 22:1685-92.
62. Helfenstein A et al. (2004) Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors. Am. J. Clin. Pathol. 122:912-8.
63. Lindstrom MS, Jin A, Deisenroth C, White Wolf G, Zhang Y. (2007) Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol. Cell. Biol. 27:1056-68.